SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Feb-24 4:55 PM View: | Gamida Cell Ltd. (GMDA) | 31-Jan-24 | Grant | 200,000 | -- | -- | 619% 32.3K to 232.3K | |
11-Oct-23 9:58 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Disposition (change in control) | 75,778 | -- | -- | (100%) 75.78K to 0 | |
15-Jun-23 4:30 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 14-Jun-23 | Sale | 115 | $0.35 | $40.03 | (< 1%) 75.89K to 75.78K | |
15-Jun-23 4:30 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 13-Jun-23 | Grant | 47,824 | -- | -- | 170% 28.07K to 75.89K | |
10-Feb-23 7:28 PM View: | Gamida Cell Ltd. (GMDA) | 08-Feb-23 | Grant | 28,300 | -- | -- | 707% 4.0K to 32.3K | |
22-Nov-22 4:36 PM View: | Gamida Cell Ltd. (GMDA) | 18-Nov-22 | Grant | 2,000 | -- | -- | 100% 2.0K to 4.0K | |
16-Jun-22 9:50 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 14-Jun-22 | Grant | 23,109 | -- | -- | 462% 5.0K to 28.11K | |
16-Jun-22 9:50 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 14-Jun-22 | Sale | 40 | $1.01 | $40.40 | (< 1%) 28.11K to 28.07K | |
05-Aug-21 10:00 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 03-Aug-21 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
17-Mar-14 9:31 PM View: | Chimerix, Inc. (CMRX) | 13-Mar-14 | Option Exercise | 15,000 | $1.57 | $23,550.00 | 283% 5.29K to 20.29K | |
17-Mar-14 9:31 PM View: | Chimerix, Inc. (CMRX) | 13-Mar-14 | Market Option Sale (Planned) | 15,000 | $25.00 | $375,000.00 | (74%) 20.29K to 5.29K | 68% |
17-Mar-14 9:31 PM View: | Chimerix, Inc. (CMRX) | 13-Mar-14 | Market Sale (Planned) | 3,979 | $25.00 | $99,475.00 | (75%) 5.29K to 1.31K | 68% |
26-Feb-14 3:40 PM View: | Chimerix, Inc. (CMRX) | 24-Feb-14 | Option Exercise | 9,072 | $1.57 | $14,243.00 | 152% 5.98K to 15.05K | |
26-Feb-14 3:40 PM View: | Chimerix, Inc. (CMRX) | 24-Feb-14 | Market Option Sale (Planned) | 9,072 | $20.00 | $181,440.00 | (60%) 15.05K to 5.98K | 61% |
26-Feb-14 3:40 PM View: | Chimerix, Inc. (CMRX) | 24-Feb-14 | Market Sale (Planned) | 2,000 | $20.00 | $40,000.00 | (33%) 5.98K to 3.98K | 61% |
03-Feb-14 8:22 PM View: | Chimerix, Inc. (CMRX) | 30-Jan-14 | Option Exercise | 928 | $1.57 | $1,456.96 | 16% 5.98K to 6.91K | |
03-Feb-14 8:22 PM View: | Chimerix, Inc. (CMRX) | 30-Jan-14 | Market Option Sale (Planned) | 928 | $20.00 | $18,560.00 | (13%) 6.91K to 5.98K | 61% |
19-Nov-13 3:07 PM View: | Chimerix, Inc. (CMRX) | 15-Nov-13 | Option Exercise | 8,479 | -- | -- | 100% 0 to 8.48K | |
19-Nov-13 3:07 PM View: | Chimerix, Inc. (CMRX) | 15-Nov-13 | Market Option Sale (Planned) | 2,500 | $15.62 | $39,040.80 | (29%) 8.48K to 5.98K | 49% |
21-Jul-06 10:00 PM View: | Synvista Therapeutics, Inc. (SYI) | 19-Jul-06 | Grant | 160,000 | -- | -- | 6% 2.8M to 2.96M |